Tetra Pak announces its collaboration with AB Biotek Human Nutrition and Health to introduce a range of innovative postbiotic food solutions. Postbiotics can be seamlessly integrated into food processing as a powder at the mixing stage of Ultra High Temperature (UHT) products, like beverages, dairy products, ice cream and cheese.
This collaboration is pivotal for the health and wellness market, estimated to grow from today’s $124.26 billion to $232.46 billion by 2030, representing an annual growth rate of 9.33 percent, according to the Global Research and Markets 2023.
Alberto Kullovitz, Tetra Pak Processing Director, South Europe, said Tetra Pak was pleased to see the launch of its first postbiotic product In Italy.
“Inalpi cheese protein slices enriched with postbiotics,” said Kullovitz.
This postbiotic innovation is not just a response to demand; it demonstrates our ambition to keep our customers ahead of market trends, no matter how fast they move. Together with AB Biotek, it has harnessed Tetra Pak’s scientific knowledge in food to bring new innovative solutions to the market.
Gerald Dard, Managing Director at AB Biotek, said that for the first time, AB Biotek can now unlock new opportunities for food producers to offer fortified products in categories such as tea, plant-based beverages, sports drinks and more.
“We are excited to embark on this exciting journey with Tetra Pak,” said Dard.
This pioneering innovation marks a significant advancement, catering to the evolving consumer demand for diversified products.
Tetra Pak is currently exploring various postbiotic food concepts, including high-protein ambient yoghurt, high-protein tea and reduced-sugar juice. This involves working with food producers throughout their product journey, from ideation to product concept testing to industrial validation at the company’s world-class Product Development Centres.
